Vertex-CRISPR’s CTX001 shows positive outcomes in trial patients
Gene-edited therapy shows promise in patients suffering from severe hemoglobinopathies. Credit: Arek Socha from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more